BNR (Burning Rock Biotech) 3-Year Book Growth Rate : -33.30% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech 3-Year Book Growth Rate?

Burning Rock Biotech's Book Value per Share for the quarter that ended in Sep. 2024 was $8.87.

During the past 12 months, Burning Rock Biotech's average Book Value per Share Growth Rate was -23.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was -33.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 7 years, the highest 3-Year average Book Value per Share Growth Rate of Burning Rock Biotech was -33.30% per year. The lowest was -33.30% per year. And the median was -33.30% per year.

Competitive Comparison of Burning Rock Biotech's 3-Year Book Growth Rate

For the Diagnostics & Research subindustry, Burning Rock Biotech's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Burning Rock Biotech's 3-Year Book Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Burning Rock Biotech's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Burning Rock Biotech's 3-Year Book Growth Rate falls into.

Burning Rock Biotech 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Burning Rock Biotech (NAS:BNR) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Burning Rock Biotech 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

6BU0:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.